Search for: "WYETH" Results 221 - 240 of 2,518
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jan 2010, 12:07 pm
For excellent schematics of Wyeth's and USPTO's differing interpretations please see this diagram from PatentDocs. [read post]
28 Oct 2007, 10:24 pm
Earlier coverage of Wyeth victories is here, here and here. [read post]
4 Nov 2008, 7:15 pm
Legal commentators have already begun speculating about the upcoming Supreme Court decision in Wyeth v. [read post]
25 Dec 2008, 3:56 pm
Check out this short and to the point article about the drug giant Wyeth paying to ghost write medical journal articles about drugs under litigation. [read post]
13 Aug 2008, 6:48 am
When we're blogging, sometimes we feel like we're doing legal research or trying to advance the law.Other times, we feel like we're just nudging our friends, so they don't overlook something that might interest them.This post is of the friendly sort:Don't overlook this article in this morning's Wall Street Journal about the intense lobbying behind the scenes in Wyeth v. [read post]
31 Oct 2008, 3:15 pm
The report actually supports Wyeth's position about the meaning of the "change being effected" (or "CBE") regulation.3. [read post]
24 Mar 2009, 7:00 am
Levine’s lawsuit against Wyeth, the manufacturer of Phenergan. [read post]
10 Sep 2010, 3:09 am by Bob Kraft
Sales of U.S. market leader Wyeth’s Prempro have fallen by about 50 percent since 2001 to around $1 billion a year. [read post]
11 Sep 2012, 6:16 am
For example, Okuda's attorneys filed suit against Wyeth and its parent company, Pfizer, way back in 2004. [read post]
11 Sep 2012, 6:16 am
For example, Okuda's attorneys filed suit against Wyeth and its parent company, Pfizer, way back in 2004. [read post]
2 Nov 2020, 2:00 am by Emma Irwin (Bristows)
Merck Sharp & Dohme Limited (MSD) sought to invalidate Wyeth LLC’s (Wyeth) patent, EP (UK) 2 676 679 (the ‘Patent’), with Wyeth maintaining that the Patent was valid and counterclaiming for infringement on a quia timet basis in relation to MSD’s V114 product. [read post]
5 Jun 2009, 2:47 am
  In the event that the primary insurer opted not to defend Wyeth in foreign suits, the endorsement provided that it would reimburse Wyeth for the reasonable cost of the investigation and defense of such suits.The excess policy expressly relieved the excess insurer of the duty to defend Wyeth. [read post]
26 Jan 2009, 6:54 am
With a headline Pfizer CEO: Wyeth Takeover Will Be Different, BusinessWeek quickly noted:Nevertheless, cost-cutting there will be. [read post]